Treating Anorectal Dysfunction in MS
Treating Anorectal Dysfunction Associated With Multiple Sclerosis
Sponsor: Consortium of Multiple Sclerosis Centers
Terminated
Poor enrollment; funding ending Dec 31, 2018.
Other terminated trials from Consortium of Multiple Sclerosis Centers
More terminations from Consortium of Multiple Sclerosis Centers
Other Constipation trials with similar outcome
This PHASE2 trial investigates Constipation and Fecal Incontinence and is currently terminated or withdrawn. Consortium of Multiple Sclerosis Centers leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jan 2019 — Feb 2020 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Consortium of Multiple Sclerosis Centers
- David Levinthal
For direct contact, visit the study record on ClinicalTrials.gov .